Literature DB >> 6092894

Purification and characterization of (-)[125I]hydroxyphenylisopropyladenosine, an adenosine R-site agonist radioligand and theoretical analysis of mixed stereoisomer radioligand binding.

J Linden.   

Abstract

(-)-N6-(R-4-Hydroxyphenylisopropyl)adenosine (HPIA) was iodinated with NaI and trace 125I. Mono- and diiodinated reaction products and the starting material were separated by high pressure liquid chromatography and the structures of the reaction products were verified by NMR. (-)-N6-(R-Phenylisopropyl)adenosine (PIA), IHPIA, and I2HPIA decreased rat atrial contractility with ED50 values of 24, 28, and 33 nM, respectively. The contractile effects of these compounds were competitively blocked by theophylline (KI = 7.9 microM), but were not affected by adenosine deaminase. IHPIA also inhibited (-)isoproterenol-stimulated cyclic AMP accumulation in adipocytes with an ED50 (10 nM) and to an extent (83%) nearly identical to PIA. [125I]HPIA prepared using carrier-free 125I bound to adenosine receptors on membranes from rat cerebral cortex, adipocyte ghosts, and heart ventricles. Binding was inhibited stereospecifically by PIA and by other adenosine analogues and alkylxanthines. The KD of [125I]HPIA determined kinetically using brain membranes at 21 degrees was 0.94 nM (K1 = 2.55 X 10(7) M-1 min-1; K-1 = 0.024 min-1) in good agreement with the equilibrium determination of 1.94 nM. The density of adenosine receptors in brain membranes was found to be 871 fmol/mg of protein. When normalized to protein, the density of receptors in heart membranes and adipocyte ghosts, respectively, was found to be 39- and 2.3-fold less than in brain membranes. We conclude that [125I]HPIA can be rapidly synthesized and purified, binds to adenosine R-sites and is an agonist radioligand resistant to adenosine deaminase. Computer modeling of the equilibrium binding resulting from the use of mixed stereoisomers of a radioligand indicates that the combined use of (-)[125I]HPIA and (+)[125I]HPIA would result in the generation of nonlinear Scatchard plots.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092894

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  10 in total

1.  Cardiac sarcolemmal purity is essential for the verification of adenylate cyclase inhibition via A1-adenosine receptors.

Authors:  W Schütz; M Freissmuth; V Hausleithner; E Tuisl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-06       Impact factor: 3.000

2.  Evidence for altered expression of the GTP-dependent regulatory proteins, Gs and Gi, in adipocytes from aged rats.

Authors:  A Green; J L Johnson
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

3.  Analysis of agonist-antagonist interactions at A1 adenosine receptors.

Authors:  E Leung; K A Jacobson; R D Green
Journal:  Mol Pharmacol       Date:  1990-07       Impact factor: 4.436

4.  Glomeruli and microvessels of the rabbit kidney contain both A1- and A2-adenosine receptors.

Authors:  M Freissmuth; V Hausleithner; E Tuisl; C Nanoff; W Schütz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

5.  Chronic administration of theophylline to rats induces a post-insulin binding defect in adipocyte glucose transport.

Authors:  A Green
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

6.  Endogenous adenosine and adenosine receptors localized to ganglion cells of the retina.

Authors:  K M Braas; M A Zarbin; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

7.  Interactions of purified bovine brain A1-adenosine receptors with G-proteins. Reciprocal modulation of agonist and antagonist binding.

Authors:  M Freissmuth; E Selzer; W Schütz
Journal:  Biochem J       Date:  1991-05-01       Impact factor: 3.857

8.  Optimal association-saturation procedure for estimating association and dissociation rate parameters in receptor studies. Application to solubilized A1 adenosine receptors.

Authors:  V Casadó; R Franco; J Mallol; C Lluis; E I Canela
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

9.  Differences in the GTP-regulation of membrane-bound and solubilized A1-adenosine receptors.

Authors:  M Ströher; C Nanoff; W Schütz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

Review 10.  Adenosine A1 and A2 receptors: structure--function relationships.

Authors:  P J van Galen; G L Stiles; G Michaels; K A Jacobson
Journal:  Med Res Rev       Date:  1992-09       Impact factor: 12.944

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.